Cambridge technology that zaps the organisms that cause hospital-acquired urinary-tract infections has been endorsed by a new study.
Read more...
BioMedTech
CamStent bug busting technology endorsed by new study
Hi-tech memory test to diagnose Alzheimer’s
Cambridge Cognition has launched a new touch-screen test for early diagnosis of dementia.
F-Star lines up €492m Merck bonanza
F-Star, the antibody engineering company based in Cambridge, has signed a deal with Merck Serono that could lead to a €492m windfall.
Tristel lights a Fuse in China
Tristel plc, the UK infection control manufacturer, has received a major boost in China.
Ubisense technology tracks dementia sufferers
Cambridge location technology has been used in a milestone study of dementia sufferers at a US university.
BioBullet fired by £500k TSB grant
Cambridge University spinout, BioBullets Ltd, has won a £500k grant from the Technology Strategy Board to advance commercialisation of its pest control technology for water treatment plants and power facilities.
Lumora eyes Africa and India after 3M US success
A switch to a clinical diagnostics focus has starting paying global dividends for Cambridge University spin-out Lumora.
NRP and Cambridge angels seek science innovators for new launchpad
Innovative science-based businesses looking for angel investment will benefit from a new initiative from Norwich Research Park in partnership with the Cambridge Capital Group.
More Articles...
- Horizon expands into AIDS-related therapy area
- Asterand fights for its life
- MISSION possible as £6m cancer spin-out eyes rapid growth
- Vernalis steps up Parkinson’s trials
- Drug enabler opens Boston hub
- PneumaCare targets Europe and US
- Boost to Atlantic Healthcare’s £2m funding round
- Dolomite-Cavendish alliance to boost cancer diagnosis
- Cancer results boost Sareum
- Phytopharm confident of clinical progress
- Skin repair firm steps up R & D with new funds
- Health Axis Europe launches funding initiative
Page 58 of 88
